At first glance, one might think that telemedicine wouldn’t be the best medium for diagnosing and treating patients with infectious diseases (IDs). There is, after all, nothing to “listen to” in conditions of sepsis, infected wounds from diabetes or other ailments, meningitis, osteomyelitis, methicillin-susceptible Staphylococcus aureus (MSSA) or other infections—nothing a stethoscope on a videoconferencing cart can pick up from the sound of a patient’s heartbeat or stomach. But look again.
It was abundantly clear in 2018 that there is a new reality in U.S. inpatient care. As I wrote in my year-end blog last month, most hospitals across the country have embraced the value equation telemedicine offers. No longer viewed as a novelty, telemedicine will continue to gain ground in hospitals in 2019—both in general hospitalist services and in a wider range of specialty offerings.